ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,317Medicare Part D Prescriptions Filled, Including Refills

Rank: 263 out of 2604

$466K Total Retail Price of All Prescriptions

Rank: 261 out of 2604

348 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 6,055 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 314 140 S3 1 1
SIMVASTATIN 215 190 2 2
LISINOPRIL 205 196 3 3
LEVOTHYROXINE SODIUM 202 195 4 4
OMEPRAZOLE 166 148 5 5
FUROSEMIDE 164 158 6 8
METFORMIN HCL 149 100 7 7
CARVEDILOL 145 122 8 26
CITALOPRAM HBR 145 132 8 18
ATENOLOL 131 110 10 11
LANTUS 130 118 11 40
BUMETANIDE 128 128 12 70
POLYETHYLENE GLYCOL 3350 115 115 13 42
TRAMADOL HCL 99 70 14 15
DONEPEZIL HCL 92 88 15 28
LOVASTATIN 82 70 16 24
POTASSIUM CHLORIDE 81 74 17 16
AMLODIPINE BESYLATE 79 71 18 6
SERTRALINE HCL 76 64 19 23
GABAPENTIN 76 63 19 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 55 21 22
CELEBREX 72 67 22 114
JANTOVEN 70 70 23 118
PRAVASTATIN SODIUM 67 49 24 14
TAMSULOSIN HCL 67 48 24 30
ISOSORBIDE MONONITRATE ER 64 64 26 38
ESCITALOPRAM OXALATE 62 58 27 73
DIGOXIN 62 62 27 71
METOPROLOL TARTRATE 57 55 29 9
ADVAIR DISKUS 56 54 30 41
NAMENDA 54 54 31 37
LACTULOSE 53 53 32 108
ROPINIROLE HCL 51 43 33 102
NOVOLOG 50 44 34 89
CRESTOR 50 43 34 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.